Cue Health Makes De Novo Submission to FDA For Full Clearance Of Its Cue Flu Molecular Test
SAN DIEGO, Sept. 1, 2022 /PRNewswire/ -- Cue Health ("Cue") (NASDAQ: HLTH) today announced that it has made a de novo submission to the U.S. Food and Drug Administration (FDA) for fullSAN DIEGO, Sept.